HOME >> BIOLOGY >> NEWS
Parasite, mosquito genomes complete malaria picture

Wednesday, Oct. 2, 2002 -- Genome sequences of Plasmodium falciparum, the most lethal malaria-causing parasite, and Anopheles gambiae, a mosquito that transmits the parasite to humans, are now complete, two international research teams announced today. The simultaneous publication in Science of the Anopheles genome and in Nature of the Plasmodium genome was marked by press conferences held in Washington, DC, and London.

"The sequencing of both P. falciparum and its insect vector heralds a new era in the fight against malaria. When joined with information we have about the human genome, a much fuller understanding of this disease and its transmission is now possible," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID). "NIAID is proud to have contributed to this extraordinary scientific achievement, which will speed efforts to investigate and develop control strategies for this devastating disease."

The medical, social and economic ravages of malaria are most keenly felt in Africa, where 90 percent of the up to 2.7 million annual deaths worldwide from the disease occur. Most victims are children less than 5 years old; on average, a child succumbs to malaria every 30 seconds. Malaria causes cycles of fever and chills that accompany cyclical destruction of parasite-infected red blood cells. Debilitating and life-threatening complications of malaria include severe anemia, cerebral malaria, and respiratory distress. The disease is caused by single-celled parasites of the genus Plasmodium, which are transmitted from person to person through the bite of an infected mosquito. The menace posed by malaria is increasing with the spread of drug-resistant parasite strains and insecticide-resistant mosquitoes. No vaccine exists.

The sequencing of P. falciparum resulted from an international collaboration established in 1996. Besides NIAID, consortium support came from the Wellcome Trust, the Burro
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
3-Oct-2002


Page: 1 2 3

Related biology news :

1. Bullish chemical could repel yellow fever mosquitoes
2. Proteins show promise for mosquito control
3. Cinnamon oil kills mosquitoes
4. Can we restore wetlands and leave the mosquitoes out?
5. Professor publishes book on historic mosquito wars
6. Making a friendlier mosquito
7. A&M researcher studying genes of mosquitoes
8. Progress in probing the mosquitos sense of smell
9. Transgenic mosquitoes are less fertile than their counterparts in nature
10. UC Riverside study indicates mosquito coils may cause cancer
11. First population study of GM mosquitoes highlights difficulties facing malaria control technique

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/13/2019)... ... March 13, 2019 , ... Leak Detection Associates , the leading global ... Industries, is excited to announce that it will be returning to INTERPHEX ... newly installed and highly experienced management team immediately marked Interphex as the show ...
(Date:3/9/2019)... Calif. (PRWEB) , ... March 07, 2019 , ... ... of a full day workshop presented by University of California Riverside’s EPIC ... held from 8 a.m. to 6 p.m. on Tuesday, March 17, 2019. The location ...
(Date:3/9/2019)... ... March 08, 2019 , ... Ace Laboratories, ... Well-Mints™ resveratrol + ribose hard candy lozenges ( http://www.well-mints.com ). , Well-Mints™ each ... flavored hard candy base dusted with powdered sugar. , Well-Mints'™ patented technology delivers ...
Breaking Biology News(10 mins):
(Date:3/12/2019)... (PRWEB) , ... March 11, 2019 , ... ... first hospital system in Colorado, and among the first in the nation, to ... around lab draws, IV placement and overall degree to which staff showed compassion ...
(Date:3/11/2019)... ... ... In this live webinar, the featured speakers will focus on the many attributes that ... how to use the information they have from the protocol and clinical trial knowledge, ... is properly designed and set up to ensure flawless execution. As clinical trial success ...
(Date:3/9/2019)... SAN DIEGO (PRWEB) , ... March 07, 2019 ... ... Agilent Technologies, is a pioneer in the development and commercialization of high performance, ... and PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and ...
(Date:3/5/2019)... ... March 05, 2019 , ... San Fransisko, or Sisko ... purchased him at four years old to pursue a career in dressage. According ... the most talented horse that she’d ever worked with. Unfortunately, Sisko suffered an ...
Breaking Biology Technology:
Cached News: